Cargando…

Engineering Cell Therapies for Autoimmune Diseases: From Preclinical to Clinical Proof of Concept

Autoimmune diseases are caused by a dysfunction of the acquired immune system. In a subset of autoimmune diseases, B cells escaping immune tolerance present autoantigen and produce cytokines and/or autoantibodies, resulting in systemic or organ-specific autoimmunity. Therefore, B cell depletion with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oh, Sangwook, Payne, Aimee S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association of Immunologists 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634148/ https://www.ncbi.nlm.nih.gov/pubmed/36381961 http://dx.doi.org/10.4110/in.2022.22.e37

Ejemplares similares

Macrophage-based therapy for intervertebral disc herniation: preclinical proof-of-concept
por: Ribeiro-Machado, Cláudia, et al.
Publicado: (2023)

Preclinical proof of concept for VivoVec, a lentiviral-based platform for in vivo CAR T-cell engineering
por: Michels, Kathryn R, et al.
Publicado: (2023)

Galactosialidosis: preclinical enzyme replacement therapy in a mouse model of the disease, a proof of concept
por: Cadaoas, Jaclyn, et al.
Publicado: (2020)

Itraconazole for COVID-19: preclinical studies and a proof-of-concept randomized clinical trial
por: Liesenborghs, Laurens, et al.
Publicado: (2021)

Myocardial Viability: From Proof of Concept to Clinical Practice
por: Bhat, Aditya, et al.
Publicado: (2016)

Gold Nanotheranostics: Proof-of-Concept or Clinical Tool?
por: Pedrosa, Pedro, et al.
Publicado: (2015)

Preclinical proof of concept of a tetravalent lentiviral T-cell vaccine against dengue viruses
por: Nemirov, Kirill, et al.
Publicado: (2023)

Endocardial ventricular pulsed field ablation: a proof-of-concept preclinical evaluation
por: Koruth, Jacob S, et al.
Publicado: (2020)

Preclinical Proof-of-Concept, Analytical Development, and Commercial Scale Production of Lentiviral Vector in Adherent Cells
por: Leinonen, Hanna M., et al.
Publicado: (2019)

Corrigendum to “itraconazole for COVID-19: Preclinical studies and a proof-of-concept randomized clinical trial Laurens”
por: Liesenborghs, Laurens, et al.
Publicado: (2021)

Turoctocog alfa (NovoEight®) – from design to clinical proof of concept
por: Ezban, Mirella, et al.
Publicado: (2014)

Vismodegib: the Proof of Concept in Basal Cell Carcinoma
por: Berrada, Narjiss, et al.
Publicado: (2014)

Malin restoration as proof of concept for gene therapy for Lafora disease
por: Varea, Olga, et al.
Publicado: (2022)

Enzyme replacement therapy for Farber disease: Proof-of-concept studies in cells and mice
por: He, Xingxuan, et al.
Publicado: (2017)

Targeting Therapy to The Neuromuscular Junction: Proof of Concept
por: Kusner, Linda L, et al.
Publicado: (2014)

Gene therapy for infantile malignant osteopetrosis: review of pre-clinical research and proof-of-concept for phenotypic reversal
por: Moscatelli, Ilana, et al.
Publicado: (2020)

Autoimmune Rheumatic Diseases and Vascular Function: The Concept of Autoimmune Atherosclerosis
por: Hedar, Ahmed M., et al.
Publicado: (2021)

The preclinical and clinical progress of cell sheet engineering in regenerative medicine
por: Hu, Danping, et al.
Publicado: (2023)

Preclinical and clinical pharmacology of brexanolone (allopregnanolone) for postpartum depression: a landmark journey from concept to clinic in neurosteroid replacement therapy
por: Reddy, Doodipala Samba, et al.
Publicado: (2023)

Engineered T cells and their therapeutic applications in autoimmune diseases
por: Bao, Lei, et al.
Publicado: (2022)

Proof of Concept of Home IoT Connected Vehicles
por: Kim, Younsun, et al.
Publicado: (2017)

Proof of Concept to Clinical Confirmation: Evolving Clinical Trial Designs for Targeted Agents
por: Finn, Laura, et al.
Publicado: (2012)

Systematic target actionability reviews of preclinical proof-of-concept papers to match targeted drugs to paediatric cancers
por: Schubert, Nil A., et al.
Publicado: (2020)

Tsetse fly inspired steerable bone drill—a proof of concept
por: de Kater, Esther P., et al.
Publicado: (2023)

Proof of Concept of Microbiome-Metabolome Analysis and Delayed Gluten Exposure on Celiac Disease Autoimmunity in Genetically At-Risk Infants
por: Sellitto, Maria, et al.
Publicado: (2012)

Proton Grid Therapy: A Proof-of-Concept Study
por: Henry, Thomas, et al.
Publicado: (2016)

Cardioprotective Melatonin: Translating from Proof-of-Concept Studies to Therapeutic Use
por: Baltatu, Ovidiu Constantin, et al.
Publicado: (2019)

Gut Microbiota and Host Metabolism: From Proof of Concept to Therapeutic Intervention
por: Cani, Patrice D., et al.
Publicado: (2021)

[(18)F]F-DED PET imaging of reactive astrogliosis in neurodegenerative diseases: preclinical proof of concept and first-in-human data
por: Ballweg, Anna, et al.
Publicado: (2023)

Methylome Profiling in Fabry Disease in Clinical Practice: A Proof of Concept
por: Di Risi, Teodolinda, et al.
Publicado: (2022)

Editorial: Pharmacology of autoimmune and neuroinflammatory disease from a preclinical and clinical perspective
por: Šíma, Martin, et al.
Publicado: (2023)

Preclinical Efficacy and Mechanisms of Mesenchymal Stem Cells in Animal Models of Autoimmune Diseases
por: Lee, Hong Kyung, et al.
Publicado: (2014)

FRI421 Immunomodulatory Therapy Can Improve Fertility In Women With Autoimmune Premature Ovarian Insufficiency - A Proof Of Concept Study
por: Hirschberg, Angelica Linden, et al.
Publicado: (2023)

Evaluation of Potential Targets for Fluorescence-Guided Surgery in Pediatric Ewing Sarcoma: A Preclinical Proof-of-Concept Study
por: Jeremiasse, Bernadette, et al.
Publicado: (2023)

Proof-of-Concept for Adjusted Surface Energies and Modified Fines as a Novel Concept in Particle Engineering for DPI Formulations
por: Bungert, Nicholas, et al.
Publicado: (2022)

Diet fuelling inflammatory bowel diseases: preclinical and clinical concepts
por: Adolph, Timon E, et al.
Publicado: (2022)

A Proposed Roadmap for Parkinson’s Disease Proof of Concept Clinical Trials Investigating Compounds Targeting Alpha-Synuclein
por: Merchant, Kalpana M., et al.
Publicado: (2019)

Immuno-PET: Design options and clinical proof-of-concept
por: Lugat, Alexandre, et al.
Publicado: (2022)

The Versatile Transceiver Proof of Concept
por: Troska, J, et al.
Publicado: (2009)

Proof of Concept for Cell Culture-Based Coffee
por: Aisala, Heikki, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ej66c9nsdr20vdp55e1oqpd54a